Aytu Bioscience Inc (AYTUD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AYTUD | NRSN | NRBO | ||
| Company | Aytu Bioscience Inc | Neurosense Therapeutics Ltd | Neurobo Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 4.0000 | 1.3700 | 3.43 | ||
| High | 4.1400 | 1.4200 | 3.68 | ||
| Low | 4.0000 | 1.2400 | 3.35 | ||
| Last | 4.1000 | 1.2600 | 3.68 | ||
| Change | +0.1500 | -0.0900 | +0.43 | ||
| % Change | +3.80% | -6.67% | +13.23% | ||
| Volume | 8,400 | 45,600 | 60,000 | ||
| 20-Day Average Volume | 5,830 | 178,855 | 27,100 | ||
| Previous Close | 3.9500 | 1.3500 | 3.25 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 3.8705 | 1.5160 | 3.44 | ||
| 20-Day Raw Stochastic | 55.56% | 13.16% | 65.71% | ||
| 20-Day Relative Strength | 42.11% | 41.05% | 47.70% | ||
| Weighted Alpha | -90.18 | -52.95 | -46.16 | ||
| Today's Opinion | N/A | 24% Buy | 24% Sell | ||
| Previous Opinion | N/A | 40% Buy | 40% Sell | ||
| Last Month's Opinion | N/A | 100% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.13% since 09/20/17 | -5.97% since 04/24/24 | +18.71% since 04/24/24 | ||
| Low | 3.8000 on 09/25/17 | 1.1700 on 04/26/24 | 3.00 on 04/26/24 | ||
| High | 4.1400 on 09/27/17 | 1.4200 on 05/01/24 | 3.68 on 05/01/24 | ||
| 1-Month | |||||
| %Chg | -4.65% since 08/25/17 | -31.15% since 04/01/24 | -9.36% since 04/01/24 | ||
| Low | 3.3400 on 08/28/17 | 1.1100 on 04/22/24 | 2.99 on 04/24/24 | ||
| High | 4.5000 on 09/14/17 | 2.2500 on 04/04/24 | 4.12 on 04/02/24 | ||
| 3-Month | |||||
| %Chg | -64.96% since 06/27/17 | -2.70% since 02/01/24 | -32.72% since 02/01/24 | ||
| Low | 3.3400 on 08/28/17 | 1.1000 on 02/12/24 | 2.99 on 04/24/24 | ||
| High | 12.0000 on 07/28/17 | 2.3300 on 03/01/24 | 6.75 on 03/04/24 | ||
| 6-Month | |||||
| %Chg | -77.22% since 03/27/17 | +176.74% since 11/01/23 | +9.58% since 11/01/23 | ||
| Low | 3.3400 on 08/28/17 | 0.4313 on 11/13/23 | 2.90 on 01/23/24 | ||
| High | 18.2000 on 04/03/17 | 2.3300 on 03/01/24 | 6.75 on 03/04/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 16,669 | 18,449 | 15,945 | ||
| Shares Outstanding, K | 4,220 | 13,666 | 4,906 | ||
| Annual Sales | 3,220,000 | 0 | 0 | ||
| Annual Net Income | -22,510,000 | -11,280,000 | -12,470,000 | ||
| Last Quarter Sales | 840,000 | 0 | 0 | ||
| Last Quarter Net Income | -6,750,000 | -2,950,000 | -5,310,000 | ||
| 60-Month Beta | 5.21 | 1.58 | -0.25 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.16 on 04/05/24 | -0.72 on 11/13/23 | ||
| Latest Earnings Date | 11/06/17 | 06/06/24 | 05/10/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||